A phase 3, randomized, open-label, two-arm, parallel-group, multicenter, multinational trial to compare the efficacy of rotigotine transdermal patch to that of ropinirole on early morning motor impairment and sleep disorders in subjects with early-stage, idiopathic Parkinson's disease.
Phase of Trial: Phase III
Latest Information Update: 22 Oct 2014
At a glance
- Drugs Rotigotine (Primary) ; Ropinirole
- Indications Parkinson's disease
- Focus Therapeutic Use
- Sponsors UCB
- 15 Sep 2009 UCB added as trial sponsor and affiliate as reported by ClinicalTrials.gov.
- 19 Sep 2006 New trial record.